{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:23:07Z","timestamp":1794471787043,"version":"4.9.1"},"reference-count":189,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013365","name":"Sichuan University West China Hospital","doi-asserted-by":"publisher","award":["ZYGD23022"],"award-info":[{"award-number":["ZYGD23022"]}],"id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20230243"],"award-info":[{"award-number":["BX20230243"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272333"],"award-info":[{"award-number":["82272333"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100114"],"award-info":[{"award-number":["32100114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["hLife"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.hlife.2025.06.003","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T03:00:49Z","timestamp":1749524449000},"page":"67-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Rabies virus glycoprotein: Structure, function, and antivirals"],"prefix":"10.1016","volume":"4","author":[{"given":"Yu","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueru","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7568-592X","authenticated-orcid":false,"given":"Guangwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlife.2025.06.003_bib1","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.hlife.2025.06.003_bib2","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00705-018-3814-x","article-title":"Taxonomy of the order Mononegavirales: Update 2018","volume":"163","author":"Amarasinghe","year":"2018","journal-title":"Arch Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0042-6822(62)90099-5","article-title":"Electron microscopy of nerve cells infected with street rabies virus","volume":"17","author":"Matsumoto","year":"1962","journal-title":"Virology"},{"key":"10.1016\/j.hlife.2025.06.003_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1017\/S0035869X00133829","article-title":"The spread of rabies into Europe and the probable origin of this disease in antiquity","volume":"109","author":"Adamson","year":"1977","journal-title":"J R Asiat Soc GB Irel"},{"key":"10.1016\/j.hlife.2025.06.003_bib5","first-page":"19","article-title":"The rabies situation in Western Europe","volume":"131","author":"Wandeler","year":"2008","journal-title":"Dev Biol"},{"key":"10.1016\/j.hlife.2025.06.003_bib6","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2012.0143","article-title":"Progress towards eliminating canine rabies: Policies and perspectives from Latin America and the Caribbean","volume":"368","author":"Vigilato","year":"2013","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.hlife.2025.06.003_bib7","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.01.010303","article-title":"One in a million, or one in thousand: What is the morbidity of rabies in India?","volume":"2","author":"Baxter","year":"2012","journal-title":"J Glob Health"},{"key":"10.1016\/j.hlife.2025.06.003_bib8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1474-4422(13)70038-3","article-title":"Human rabies: Neuropathogenesis, diagnosis, and management","volume":"12","author":"Hemachudha","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.hlife.2025.06.003_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QCO.0000000000000420","article-title":"Rabies: Changing prophylaxis and new insights in pathophysiology","volume":"31","author":"Ugolini","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.hlife.2025.06.003_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/13550280290100725","article-title":"Rabies pathogenesis","volume":"8","author":"Jackson","year":"2002","journal-title":"J Neurovirol"},{"key":"10.1016\/j.hlife.2025.06.003_bib11","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/v13091769","article-title":"Renewed public health threat from emerging lyssaviruses","volume":"13","author":"Fooks","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.hlife.2025.06.003_bib12","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1016\/S2214-109X(16)30245-5","article-title":"2016: The beginning of the end of rabies?","volume":"4","author":"Abela-Ridder","year":"2016","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.hlife.2025.06.003_bib13","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(13)62707-5","article-title":"Current status of rabies and prospects for elimination","volume":"384","author":"Fooks","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.hlife.2025.06.003_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/13550280590900409","article-title":"Pathophysiology of human paralytic rabies","volume":"11","author":"Hemachudha","year":"2005","journal-title":"J Neurovirol"},{"key":"10.1016\/j.hlife.2025.06.003_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.91","article-title":"Rabies","volume":"3","author":"Fooks","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hlife.2025.06.003_bib16","series-title":"Subfamily: Alpharhabdovirinae. Genus: Lyssavirus","year":"2025"},{"key":"10.1016\/j.hlife.2025.06.003_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/v13010069","article-title":"Genetic and antigenetic characterization of the novel Kotalahti bat lyssavirus (KBLV)","volume":"13","author":"Calvelage","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.hlife.2025.06.003_bib18","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1128\/jvi.15.6.1348-1356.1975","article-title":"Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus","volume":"15","author":"Emerson","year":"1975","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0042-6822(85)90348-4","article-title":"Ultrastructural localization of L and NS enzyme subunits on vesicular stomatitis virus RNPs using gold sphere-staphylococcal protein A-monospecific IgG conjugates","volume":"142","author":"Harmon","year":"1985","journal-title":"Virology"},{"key":"10.1016\/j.hlife.2025.06.003_bib20","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/jvi.64.6.2948-2957.1990","article-title":"Replication and amplification of defective interfering particle RNAs of vesicular stomatitis virus in cells expressing viral proteins from vectors containing cloned cDNAs","volume":"64","author":"Pattnaik","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/jvi.49.2.303-309.1984","article-title":"N protein alone satisfies the requirement for protein synthesis during RNA replication of vesicular stomatitis virus","volume":"49","author":"Patton","year":"1984","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib22","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1128\/jvi.67.3.1365-1372.1993","article-title":"Low-pH conformational changes of rabies virus glycoprotein and their role in membrane fusion","volume":"67","author":"Gaudin","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000994","article-title":"A spatio-temporal analysis of matrix protein and nucleocapsid trafficking during vesicular stomatitis virus uncoating","volume":"6","author":"Mire","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.hlife.2025.06.003_bib24","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.1128\/JVI.00554-09","article-title":"Functional characterization of Negri bodies (NBs) in rabies virus-infected cells: Evidence that NBs are sites of viral transcription and replication","volume":"83","author":"Lahaye","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib25","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1128\/jvi.71.5.3742-3750.1997","article-title":"Folding of rabies virus glycoprotein: Epitope acquisition and interaction with endoplasmic reticulum chaperones","volume":"71","author":"Gaudin","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-387040-7.00001-9","article-title":"Rabies virus transcription and replication","volume":"79","author":"Albertini","year":"2011","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.hlife.2025.06.003_bib27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/JVI.73.1.242-250.1999","article-title":"Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G","volume":"73","author":"Mebatsion","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2005.04.004","article-title":"Replication strategies of rabies virus","volume":"111","author":"Finke","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.hlife.2025.06.003_bib29","doi-asserted-by":"crossref","first-page":"8746","DOI":"10.1128\/JVI.78.16.8746-8752.2004","article-title":"Evidence that rabies virus forms different kinds of fusion machines with different pH thresholds for fusion","volume":"78","author":"Roche","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib30","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3390\/v5020678","article-title":"Directional spread of alphaherpesviruses in the nervous system","volume":"5","author":"Kramer","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.hlife.2025.06.003_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13365-013-0180-z","article-title":"The neuroimmune response to West Nile virus","volume":"20","author":"Fredericksen","year":"2014","journal-title":"J Neurovirol"},{"key":"10.1016\/j.hlife.2025.06.003_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004348","article-title":"Rabies virus hijacks and accelerates the p75NTR retrograde axonal transport machinery","volume":"10","author":"Gluska","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.hlife.2025.06.003_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.01342-07","article-title":"Double-labeled rabies virus: Live tracking of enveloped virus transport","volume":"82","author":"Klingen","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1128\/jvi.55.1.158-162.1985","article-title":"Pathways of the early propagation of virulent and avirulent rabies strains from the eye to the brain","volume":"55","author":"Kucera","year":"1985","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00005072-197905000-00008","article-title":"Evidence for an intraaxonal transport of fixed and street rabies virus","volume":"38","author":"Tsiang","year":"1979","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.hlife.2025.06.003_bib36","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00005072-198611000-00002","article-title":"Axonal transport of rabies virus in the central nervous system of the rat","volume":"45","author":"Gillet","year":"1986","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.hlife.2025.06.003_bib37","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/jvi.61.9.2733-2741.1987","article-title":"Rabies virus infection of cultured rat sensory neurons","volume":"61","author":"Lycke","year":"1987","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymthe.2003.09.017","article-title":"Transduction patterns of pseudotyped lentiviral vectors in the nervous system","volume":"9","author":"Wong","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.hlife.2025.06.003_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005753","article-title":"Rabies internalizes into primary peripheral neurons via clathrin coated pits and requires fusion at the cell body","volume":"12","author":"Piccinotti","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.hlife.2025.06.003_bib40","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1099\/0022-1317-81-9-2147","article-title":"Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: An in vitro and in vivo study","volume":"81","author":"Etessami","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/B978-0-12-387040-7.00010-X","article-title":"Rabies virus as a transneuronal tracer of neuronal connections","volume":"79","author":"Ugolini","year":"2011","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.hlife.2025.06.003_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s13365-013-0179-5","article-title":"In vivo differential susceptibility of sensory neurons to rabies virus infection","volume":"19","author":"Velandia-Romero","year":"2013","journal-title":"J Neurovirol"},{"key":"10.1016\/j.hlife.2025.06.003_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.virusres.2019.02.006","article-title":"Early events in rabies virus infection\u2014Attachment, entry, and intracellular trafficking","volume":"263","author":"Guo","year":"2019","journal-title":"Virus Res"},{"key":"10.1016\/j.hlife.2025.06.003_bib44","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/hmg\/10.19.2109","article-title":"Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery","volume":"10","author":"Mazarakis","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hlife.2025.06.003_bib45","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jneumeth.2006.04.011","article-title":"Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1-based vectors pseudotyped with select rabies virus glycoproteins","volume":"157","author":"Mentis","year":"2006","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.hlife.2025.06.003_bib46","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2007.01.033","article-title":"Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons","volume":"53","author":"Wickersham","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.hlife.2025.06.003_bib47","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.neuron.2011.07.005","article-title":"New rabies virus variants for monitoring and manipulating activity and gene expression in defined neural circuits","volume":"71","author":"Osakada","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.hlife.2025.06.003_bib48","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.neuron.2015.05.001","article-title":"Locomotion, theta oscillations, and the speed-correlated firing of hippocampal neurons are controlled by a medial septal glutamatergic circuit","volume":"86","author":"Fuhrmann","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.hlife.2025.06.003_bib49","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.celrep.2012.10.008","article-title":"Charting monosynaptic connectivity maps by two-color light-sheet fluorescence microscopy","volume":"2","author":"Niedworok","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.hlife.2025.06.003_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.30697","article-title":"Aversive stimuli drive hypothalamus-to-habenula excitation to promote escape behavior","volume":"6","author":"Lecca","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.hlife.2025.06.003_bib51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuron.2016.08.034","article-title":"Dysfunction of somatostatin-positive interneurons associated with memory deficits in an Alzheimer's disease model","volume":"92","author":"Schmid","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.hlife.2025.06.003_bib52","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0092-8674(00)81072-7","article-title":"Budding of rabies virus particles in the absence of the spike glycoprotein","volume":"84","author":"Mebatsion","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.hlife.2025.06.003_bib53","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1126\/science.7053569","article-title":"Is the acetylcholine receptor a rabies virus receptor?","volume":"215","author":"Lentz","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.hlife.2025.06.003_bib54","first-page":"315","article-title":"The acetylcholine receptor as a cellular receptor for rabies virus","volume":"56","author":"Lentz","year":"1983","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.hlife.2025.06.003_bib55","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/13550280590900427","article-title":"Rabies virus receptors","volume":"11","author":"Lafon","year":"2005","journal-title":"J Neurovirol"},{"key":"10.1016\/j.hlife.2025.06.003_bib56","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1128\/JVI.72.9.7181-7190.1998","article-title":"The neural cell adhesion molecule is a receptor for rabies virus","volume":"72","author":"Thoulouze","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib57","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/jnr.20530","article-title":"Neural cell adhesion molecule function is regulated by metalloproteinase-mediated ectodomain release","volume":"80","author":"H\u00fcbschmann","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.hlife.2025.06.003_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.736114","article-title":"Structural and evolutionary insights into the binding of host receptors by the rabies virus glycoprotein","volume":"11","author":"Khalifa","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.hlife.2025.06.003_bib59","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1093\/emboj\/17.24.7250","article-title":"Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus","volume":"17","author":"Tuffereau","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.hlife.2025.06.003_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007189","article-title":"Metabotropic glutamate receptor subtype 2 is a cellular receptor for rabies virus","volume":"14","author":"Wang","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.hlife.2025.06.003_bib61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.brainres.2008.10.055","article-title":"The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival","volume":"1249","author":"Lee","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.hlife.2025.06.003_bib62","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0168-1702(85)90014-0","article-title":"Rabies virus binding at neuromuscular junctions","volume":"2","author":"Burrage","year":"1985","journal-title":"Virus Res"},{"key":"10.1016\/j.hlife.2025.06.003_bib63","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.ph.57.030195.002513","article-title":"Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons","volume":"57","author":"McGehee","year":"1995","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.hlife.2025.06.003_bib64","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/prot.340020406","article-title":"Synthetic peptides corresponding to sequences of snake venom neurotoxins and rabies virus glycoprotein bind to the nicotinic acetylcholine receptor","volume":"2","author":"Lentz","year":"1987","journal-title":"Proteins"},{"key":"10.1016\/j.hlife.2025.06.003_bib65","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1126\/science.6494916","article-title":"Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins","volume":"226","author":"Lentz","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.hlife.2025.06.003_bib66","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0161-5890(88)90125-3","article-title":"Antipeptide monoclonal antibodies inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor","volume":"25","author":"Bracci","year":"1988","journal-title":"Mol Immunol"},{"key":"10.1016\/j.hlife.2025.06.003_bib67","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0304-3940(97)00440-0","article-title":"Partial inhibition of the in vitro infection of adult mouse dorsal root ganglion neurons by rabies virus using nicotinic antagonists","volume":"229","author":"Castellanos","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.hlife.2025.06.003_bib68","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/j.1460-2075.1989.tb03389.x","article-title":"Differential exon usage involving an unusual splicing mechanism generates at least eight types of NCAM cDNA in mouse brain","volume":"8","author":"Santoni","year":"1989","journal-title":"EMBO J"},{"key":"10.1016\/j.hlife.2025.06.003_bib69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/19490992.2015.1118194","article-title":"Intracellular transport and cell surface delivery of the neural cell adhesion molecule (NCAM)","volume":"5","author":"Leshchyns'ka","year":"2015","journal-title":"BioArchitecture"},{"key":"10.1016\/j.hlife.2025.06.003_bib70","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-3-642-45106-5_6","article-title":"The biological functions and signaling mechanisms of the p75 neurotrophin receptor","volume":"220","author":"Kraemer","year":"2014","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.hlife.2025.06.003_bib71","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0301-0082(02)00016-3","article-title":"Neurotrophin signaling through the p75 neurotrophin receptor","volume":"67","author":"Roux","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.hlife.2025.06.003_bib72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biopha.2015.10.010","article-title":"Update on the role of p75NTR in neurological disorders: A novel therapeutic target","volume":"76","author":"Shu","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.hlife.2025.06.003_bib73","doi-asserted-by":"crossref","first-page":"37655","DOI":"10.1074\/jbc.M201374200","article-title":"Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor","volume":"277","author":"Langevin","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hlife.2025.06.003_bib74","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1099\/vir.0.81063-0","article-title":"Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75NTR receptor","volume":"86","author":"Sisso\u00ebff","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib75","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1099\/0022-1317-82-12-2861","article-title":"Interaction of lyssaviruses with the low-affinity nerve-growth factor receptor p75NTR","volume":"82","author":"Tuffereau","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib76","doi-asserted-by":"crossref","first-page":"13622","DOI":"10.1128\/JVI.02368-06","article-title":"The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection","volume":"81","author":"Tuffereau","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib77","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1124\/mol.63.1.183","article-title":"Specificity of metabotropic glutamate receptor 2 coupling to G proteins","volume":"63","author":"Kammermeier","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.hlife.2025.06.003_bib78","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0306-4522(93)90485-X","article-title":"Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat","volume":"53","author":"Ohishi","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.hlife.2025.06.003_bib79","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/infdis\/jiy081","article-title":"The role of heparan sulfate proteoglycans as an attachment factor for rabies virus entry and infection","volume":"217","author":"Sasaki","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.hlife.2025.06.003_bib80","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1099\/0022-1317-65-4-781","article-title":"Mechanism of rabies virus entry into CER cells","volume":"65","author":"Superti","year":"1984","journal-title":"J Gen Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib81","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000149696","article-title":"Membrane carbohydrate requirement for rabies virus binding to chicken embryo related cells","volume":"26","author":"Conti","year":"1986","journal-title":"Intervirology"},{"key":"10.1016\/j.hlife.2025.06.003_bib82","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.virol.2015.03.043","article-title":"Viral membrane fusion","volume":"479\u2012480","author":"Harrison","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.hlife.2025.06.003_bib83","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.sbi.2007.08.016","article-title":"Structural basis of viral invasion: Lessons from paramyxovirus F","volume":"17","author":"Lamb","year":"2007","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.hlife.2025.06.003_bib84","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 \u00c5 resolution","volume":"289","author":"Wilson","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.hlife.2025.06.003_bib85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/371037a0","article-title":"Structure of influenza haemagglutinin at the pH of membrane fusion","volume":"371","author":"Bullough","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.hlife.2025.06.003_bib86","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-5793(99)01475-1","article-title":"Structure of influenza haemagglutinin at neutral and at fusogenic pH by electron Cryo-microscopy","volume":"463","author":"Bottcher","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.hlife.2025.06.003_bib87","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(00)80205-6","article-title":"Core structure of gp41 from the HIV envelope glycoprotein","volume":"89","author":"Chan","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.hlife.2025.06.003_bib88","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/387426a0","article-title":"Atomic structure of the ectodomain from HIV-1 gp41","volume":"387","author":"Weissenhorn","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.hlife.2025.06.003_bib89","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature17200","article-title":"Pre-fusion structure of a human coronavirus spike protein","volume":"531","author":"Kirchdoerfer","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.hlife.2025.06.003_bib90","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.hlife.2025.06.003_bib187","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.hlife.2024.02.001","article-title":"A human monoclonal antibody neutralizes SARS-CoV-2 Omicron variants by targeting the upstream region of spike protein HR2 motif","volume":"2","author":"Su","year":"2024","journal-title":"hLife"},{"key":"10.1016\/j.hlife.2025.06.003_bib91","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1097-2765(00)80159-8","article-title":"Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain","volume":"2","author":"Weissenhorn","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.hlife.2025.06.003_bib92","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.hlife.2025.06.003_bib93","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1083\/jcb.116.2.339","article-title":"Membrane fusion process of Semliki Forest virus. I: Low pH-induced rearrangement in spike protein quaternary structure precedes virus penetration into cells","volume":"116","author":"Wahlberg","year":"1992","journal-title":"J Cell Biol"},{"key":"10.1016\/j.hlife.2025.06.003_bib94","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1128\/jvi.70.11.8142-8147.1996","article-title":"Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus","volume":"70","author":"Stiasny","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib95","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2 \u00c5 resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.hlife.2025.06.003_bib96","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.hlife.2025.06.003_bib97","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.hlife.2025.06.003_bib98","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-8674(01)00303-8","article-title":"The fusion glycoprotein shell of Semliki Forest virus: An icosahedral assembly primed for fusogenic activation at endosomal pH","volume":"105","author":"Lescar","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.hlife.2025.06.003_bib99","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nature02239","article-title":"Conformational change and protein\u2013protein interactions of the fusion protein of Semliki Forest virus","volume":"427","author":"Gibbons","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.hlife.2025.06.003_bib100","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1135710","article-title":"Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G","volume":"315","author":"Roche","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.hlife.2025.06.003_bib101","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1126\/science.1127683","article-title":"Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G","volume":"313","author":"Roche","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.hlife.2025.06.003_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004756","article-title":"Structure of the low pH conformation of Chandipura virus G reveals important features in the evolution of the vesiculovirus glycoprotein","volume":"11","author":"Baquero","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.hlife.2025.06.003_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012923","article-title":"Structures of two lyssavirus glycoproteins trapped in pre- and post-fusion states and the implications on the spatial-temporal conformational transition along with pH-decrease","volume":"21","author":"Yang","year":"2025","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.hlife.2025.06.003_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008383","article-title":"Crystal structure of Mokola virus glycoprotein in its post-fusion conformation","volume":"16","author":"Belot","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.hlife.2025.06.003_bib105","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.chom.2019.12.012","article-title":"Structural analysis of rabies virus glycoprotein reveals pH-dependent conformational changes and interactions with a neutralizing antibody","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.hlife.2025.06.003_bib106","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.chom.2022.07.014","article-title":"Structure of trimeric pre-fusion rabies virus glycoprotein in complex with two protective antibodies","volume":"30","author":"Ng","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.hlife.2025.06.003_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abp9151","article-title":"Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"8","author":"Callaway","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.hlife.2025.06.003_bib108","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1126548","article-title":"Crystal structure of glycoprotein B from herpes simplex virus 1","volume":"313","author":"Heldwein","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.hlife.2025.06.003_bib109","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1073\/pnas.0810530106","article-title":"Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B","volume":"106","author":"Backovic","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.hlife.2025.06.003_bib110","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nsmb.1484","article-title":"The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines","volume":"15","author":"Kadlec","year":"2008","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.hlife.2025.06.003_bib111","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/v4010117","article-title":"Molecular and cellular aspects of rhabdovirus entry","volume":"4","author":"Albertini","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.hlife.2025.06.003_bib112","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/viro.2002.1429","article-title":"Characterization of the equilibrium between the native and fusion-inactive conformation of rabies virus glycoprotein indicates that the fusion complex is made of several trimers","volume":"297","author":"Roche","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.hlife.2025.06.003_bib113","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1128\/jvi.65.9.4853-4859.1991","article-title":"Reversible conformational changes and fusion activity of rabies virus glycoprotein","volume":"65","author":"Gaudin","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002556","article-title":"Characterization of monomeric intermediates during VSV glycoprotein structural transition","volume":"8","author":"Albertini","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.hlife.2025.06.003_bib115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.coviro.2013.03.006","article-title":"Intermediate conformations during viral fusion glycoprotein structural transition","volume":"3","author":"Baquero","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib116","first-page":"E28","article-title":"Mechanism of membrane fusion induced by vesicular stomatitis virus G protein","volume":"114","author":"Kim","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.hlife.2025.06.003_bib117","doi-asserted-by":"crossref","first-page":"679","DOI":"10.15252\/embj.201694565","article-title":"Structural intermediates in the fusion-associated transition of vesiculovirus glycoprotein","volume":"36","author":"Baquero","year":"2017","journal-title":"EMBO J"},{"key":"10.1016\/j.hlife.2025.06.003_bib118","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1128\/JVI.78.8.4342-4351.2004","article-title":"Reptilian reovirus utilizes a small type III protein with an external myristylated amino terminus to mediate cell\u2013cell fusion","volume":"78","author":"Corcoran","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib119","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1128\/JVI.79.10.6216-6226.2005","article-title":"Unusual topological arrangement of structural motifs in the baboon reovirus fusion-associated small transmembrane protein","volume":"79","author":"Dawe","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib120","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/emboj\/19.5.902","article-title":"A new class of fusion-associated small transmembrane (FAST) proteins encoded by the non-enveloped fusogenic reoviruses","volume":"19","author":"Shmulevitz","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.hlife.2025.06.003_bib121","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/0-306-46824-7_10","article-title":"Reversibility in fusion protein conformational changes. The intriguing case of rhabdovirus-induced membrane fusion","volume":"34","author":"Gaudin","year":"2000","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.hlife.2025.06.003_bib122","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1083\/jcb.201006116","article-title":"Distinct structural rearrangements of the VSV glycoprotein drive membrane fusion","volume":"191","author":"Libersou","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1016\/j.hlife.2025.06.003_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.142570","article-title":"Molecular basis of two broad-spectrum antibodies neutralizing rabies virus and other phylogroup-I lyssaviruses by blocking structural transition between the pleckstrin-homology and fusion domains in the glycoprotein","volume":"308","author":"Yang","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.hlife.2025.06.003_bib124","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0042-6822(92)90465-2","article-title":"Rabies virus glycoprotein is a trimer","volume":"187","author":"Gaudin","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.hlife.2025.06.003_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.632957","article-title":"Change in the single amino acid site 83 in rabies virus glycoprotein enhances the BBB permeability and reduces viral pathogenicity","volume":"8","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.hlife.2025.06.003_bib126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/13550280490279799","article-title":"Region at amino acids 164 to 303 of the rabies virus glycoprotein plays an important role in pathogenicity for adult mice","volume":"10","author":"Takayama-Ito","year":"2004","journal-title":"J Neurovirol"},{"key":"10.1016\/j.hlife.2025.06.003_bib127","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1348-0421.2009.00192.x","article-title":"Amino acid substitutions at positions 242, 255 and 268 in rabies virus glycoprotein affect spread of viral infection","volume":"54","author":"Ito","year":"2010","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.hlife.2025.06.003_bib128","doi-asserted-by":"crossref","first-page":"9650","DOI":"10.1096\/fj.201902577R","article-title":"Single amino acid change at position 255 in rabies virus glycoprotein decreases viral pathogenicity","volume":"34","author":"Luo","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.hlife.2025.06.003_bib129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biologicals.2022.06.004","article-title":"Study on an attenuated rabies virus strain CTN181-3","volume":"78","author":"Shi","year":"2022","journal-title":"Biologicals"},{"key":"10.1016\/j.hlife.2025.06.003_bib130","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3390\/pathogens11121556","article-title":"Evolution of rabies virus isolates: Virulence signatures and effects of modulation by neutralizing antibodies","volume":"11","author":"Conselheiro","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.hlife.2025.06.003_bib131","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.virusres.2006.01.014","article-title":"A highly attenuated rabies virus HEP-Flury strain reverts to virulent by single amino acid substitution to arginine at position 333 in glycoprotein","volume":"119","author":"Takayama-Ito","year":"2006","journal-title":"Virus Res"},{"key":"10.1016\/j.hlife.2025.06.003_bib146","article-title":"Clofazimine: A promising inhibitor of rabies virus","volume":"12","author":"Wu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.hlife.2025.06.003_bib147","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00321-20","article-title":"Identification and characterization of a small-molecule rabies virus entry inhibitor","volume":"94","author":"Du Pont","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib132","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","article-title":"Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants","volume":"79","author":"Bakker","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib133","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1128\/jvi.64.6.3087-3090.1990","article-title":"Biological characterization of human monoclonal antibodies to rabies virus","volume":"64","author":"Dietzschold","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib134","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.med.58.061705.145053","article-title":"A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis","volume":"58","author":"de Kruif","year":"2007","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.hlife.2025.06.003_bib135","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","article-title":"Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: Fine mapping and escape mutant analysis","volume":"79","author":"Marissen","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/jvi.62.1.1-7.1988","article-title":"Antigenic site II of the rabies virus glycoprotein: Structure and role in viral virulence","volume":"62","author":"Prehaud","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib137","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1099\/0022-1317-70-2-291","article-title":"Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein","volume":"70","author":"Bunschoten","year":"1989","journal-title":"J Gen Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib138","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/jvi.65.8.4198-4203.1991","article-title":"Antigenicity of rabies virus glycoprotein","volume":"65","author":"Benmansour","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib139","doi-asserted-by":"crossref","first-page":"407","DOI":"10.15252\/emmm.201505986","article-title":"Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis","volume":"8","author":"De Benedictis","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.hlife.2025.06.003_bib140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/375247","article-title":"Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies","volume":"188","author":"Prosniak","year":"2003","journal-title":"J Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.hlife.2025.06.003_bib141","doi-asserted-by":"crossref","first-page":"S785","DOI":"10.1093\/clinids\/10.Supplement_4.S785","article-title":"Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: Implications for epidemiology and control of rabies","volume":"10","author":"Dietzschold","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.hlife.2025.06.003_bib142","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00253-012-4171-4","article-title":"Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein","volume":"96","author":"Sun","year":"2012","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.hlife.2025.06.003_bib143","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41467-020-14398-7","article-title":"Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein","volume":"11","author":"Hellert","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.hlife.2025.06.003_bib144","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28954","article-title":"Characterization of a human-mouse chimeric monoclonal antibody targeting rabies virus glycoprotein","volume":"95","author":"Cai","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.hlife.2025.06.003_bib186","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.str.2024.10.002","article-title":"Structural insight into rabies virus neutralization revealed by an engineered antibody scaffold","volume":"32","author":"Kedari","year":"2024","journal-title":"Structure"},{"key":"10.1016\/j.hlife.2025.06.003_bib145","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2013.01.003","article-title":"Current and future approaches to the therapy of human rabies","volume":"99","author":"Jackson","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.hlife.2025.06.003_bib148","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/138945007779315524","article-title":"Targeting purine and pyrimidine metabolism in human apicomplexan parasites","volume":"8","author":"Hyde","year":"2007","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.hlife.2025.06.003_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2018.10.016","article-title":"Pyrimethamine inhibits rabies virus replication in vitro","volume":"161","author":"Rog\u00e9e","year":"2019","journal-title":"Antivir Res"},{"key":"10.1016\/j.hlife.2025.06.003_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2018.03.011","article-title":"Ribavirin-related compounds exert in vitro inhibitory effects toward rabies virus","volume":"154","author":"Anindita","year":"2018","journal-title":"Antivir Res"},{"key":"10.1016\/j.hlife.2025.06.003_bib151","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.3390\/v15122292","article-title":"A robust phenotypic high-throughput antiviral assay for the discovery of rabies virus inhibitors","volume":"15","author":"Wang","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.hlife.2025.06.003_bib152","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1016\/j.vaccine.2017.10.109","article-title":"Re-evaluating the effect of favipiravir treatment on rabies virus infection","volume":"37","author":"Banyard","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.hlife.2025.06.003_bib153","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03679","article-title":"Favipiravir elicits antiviral mutagenesis during virus replication in vivo","volume":"3","author":"Arias","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.hlife.2025.06.003_bib154","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/v10040201","article-title":"Inhibition of rabies virus by 1,2,3,4,6-penta-O-galloyl-\u03b2-d-glucose involves mTOR-dependent autophagy","volume":"10","author":"Tu","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.hlife.2025.06.003_bib155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.toxicon.2020.08.014","article-title":"The anti-rabies activity of Caspian cobra venom","volume":"186","author":"Farzad","year":"2020","journal-title":"Toxicon"},{"key":"10.1016\/j.hlife.2025.06.003_bib156","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.3390\/ijms24065851","article-title":"RVG peptide-functionalized favipiravir nanoparticle delivery system facilitates antiviral therapy of neurotropic virus infection in a mouse model","volume":"24","author":"Ren","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hlife.2025.06.003_bib157","series-title":"WHO expert consultation on rabies: Third report","year":"2018"},{"key":"10.1016\/j.hlife.2025.06.003_bib158","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/cid\/cix791","article-title":"Comparison of a novel human rabies monoclonal antibody to human rabies immunoglobulin for postexposure prophylaxis: A Phase 2\/3, randomized, single-blind, noninferiority, controlled study","volume":"66","author":"Gogtay","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.hlife.2025.06.003_bib159","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/df98339d-6bdb-40ed-af83-cc38b249264a","article-title":"Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans","volume":"3","author":"M\u00fcller","year":"2009","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.hlife.2025.06.003_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102267","article-title":"Efficacy of ormutivimab, a novel recombinant human anti-rabies monoclonal antibody, in post-exposure prophylaxis animal models","volume":"46","author":"Zhai","year":"2022","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.hlife.2025.06.003_bib161","first-page":"31","article-title":"In vivo efficacy of SYN023, an anti-rabies monoclonal antibody cocktail, in post-exposure prophylaxis animal models","volume":"5","author":"Chao","year":"2020","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.hlife.2025.06.003_bib162","first-page":"48","article-title":"In vivo efficacy of a cocktail of human monoclonal antibodies (CL184) against diverse North American bat rabies virus variants","volume":"2","author":"Franka","year":"2017","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.hlife.2025.06.003_bib163","article-title":"A broad-spectrum and highly potent human monoclonal antibody cocktail for rabies prophylaxis","volume":"16","author":"Kim","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.hlife.2025.06.003_bib164","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1586\/14760584.2016.1140040","article-title":"Current status and development of vaccines and other biologics for human rabies prevention","volume":"15","author":"Rupprecht","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.hlife.2025.06.003_bib165","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1286-4579(03)00075-3","article-title":"Louis Pasteur (1822\u20121895)","volume":"5","author":"Bordenave","year":"2003","journal-title":"Microb Infect"},{"key":"10.1016\/j.hlife.2025.06.003_bib166","first-page":"1","article-title":"Human rabies prevention---United States, 2008: Recommendations of the advisory committee on immunization practices","volume":"57","author":"Manning","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.hlife.2025.06.003_bib167","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/jama.1956.02970320021006","article-title":"Duck-embryo rabies vaccine; study of fixed virus vaccine grown in embryonated duck eggs and killed with \u03b2-propiolactone (BPL)","volume":"162","author":"Culbertson","year":"1956","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.hlife.2025.06.003_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2022.101204","article-title":"Monoclonal antibodies against rabies: Current uses in prophylaxis and in therapy","volume":"53","author":"de Melo","year":"2022","journal-title":"Curr Opin Virol"},{"issue":"Suppl 4","key":"10.1016\/j.hlife.2025.06.003_bib169","doi-asserted-by":"crossref","first-page":"S739","DOI":"10.1093\/clinids\/10.Supplement_4.S739","article-title":"Animal models in the pathogenesis and treatment of rabies","volume":"10","author":"Baer","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.hlife.2025.06.003_bib170","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1073\/pnas.93.14.7310","article-title":"Highly stable expression of a foreign gene from rabies virus vectors","volume":"93","author":"Mebatsion","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.hlife.2025.06.003_bib171","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1348-0421.2006.tb03785.x","article-title":"Characterization of recombinant rabies virus carrying double glycoprotein genes","volume":"50","author":"Hosokawa-Muto","year":"2006","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.hlife.2025.06.003_bib172","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1016\/j.vaccine.2008.08.069","article-title":"Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene","volume":"26","author":"Cenna","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.hlife.2025.06.003_bib173","article-title":"A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.hlife.2025.06.003_bib174","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11262-014-1049-9","article-title":"An inactivated recombinant rabies CVS-11 virus expressing two copies of the glycoprotein elicits a higher level of neutralizing antibodies and provides better protection in mice","volume":"48","author":"Xue","year":"2014","journal-title":"Virus Genes"},{"key":"10.1016\/j.hlife.2025.06.003_bib175","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3855\/jidc.19193","article-title":"A single dose of recombinant adenoviral vector rabies vaccine expressing two copies of glycoprotein protects mice from lethal virus challenge","volume":"18","author":"Li","year":"2024","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.hlife.2025.06.003_bib176","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2022.2149351","article-title":"A rabies virus-vectored vaccine expressing two copies of the Marburg virus glycoprotein gene induced neutralizing antibodies against Marburg virus in humanized mice","volume":"12","author":"Bi","year":"2023","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.hlife.2025.06.003_bib189","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.hlife.2024.09.002","article-title":"Comparison of antigen-specific B cell responses reveals disparity in immunogenicity and memory B cell formation across COVID-19 vaccine platforms","volume":"2","author":"Guo","year":"2024","journal-title":"hLife"},{"key":"10.1016\/j.hlife.2025.06.003_bib177","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1038\/s41467-024-52908-z","article-title":"Self-assembling nanoparticle engineered from the ferritinophagy complex as a rabies virus vaccine candidate","volume":"15","author":"Fu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.hlife.2025.06.003_bib190","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.hlife.2025.04.008","article-title":"Systemic profiling of immune responses in healthy adults vaccinated with an RBD-targeting COVID-19 mRNA vaccine","volume":"3","author":"Zhou","year":"2025","journal-title":"hLife"},{"key":"10.1016\/j.hlife.2025.06.003_bib178","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12985-022-01919-7","article-title":"An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs","volume":"19","author":"Li","year":"2022","journal-title":"Virol J"},{"key":"10.1016\/j.hlife.2025.06.003_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106425","article-title":"A novel mRNA rabies vaccine as a promising candidate for rabies post-exposure prophylaxis protects animals from different rabies viruses","volume":"185","author":"Yu","year":"2023","journal-title":"Microb Pathog"},{"key":"10.1016\/j.hlife.2025.06.003_bib180","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1038\/s41467-023-39421-5","article-title":"Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses","volume":"14","author":"Hellgren","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.hlife.2025.06.003_bib181","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1016\/j.vaccine.2023.10.019","article-title":"Immunogenicity of rabies virus G mRNA formulated with lipid nanoparticles and nucleic acid immunostimulators in mice","volume":"41","author":"Qiao","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.hlife.2025.06.003_bib182","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2270081","article-title":"A single immunization with core-shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs","volume":"12","author":"Wan","year":"2023","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.hlife.2025.06.003_bib183","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2389115","article-title":"A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice","volume":"13","author":"Liu","year":"2024","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.hlife.2025.06.003_bib184","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-12-387040-7.00003-2","article-title":"Evasive strategies in rabies virus infection","volume":"79","author":"Lafon","year":"2011","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.hlife.2025.06.003_bib185","doi-asserted-by":"crossref","first-page":"11637","DOI":"10.1128\/JVI.01648-13","article-title":"Uptake of rabies virus into epithelial cells by clathrin-mediated endocytosis depends upon actin","volume":"87","author":"Piccinotti","year":"2013","journal-title":"J Virol"}],"container-title":["hLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949928325000628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949928325000628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:53:06Z","timestamp":1777639986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949928325000628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":189,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2949928325000628"],"URL":"https:\/\/doi.org\/10.1016\/j.hlife.2025.06.003","relation":{},"ISSN":["2949-9283"],"issn-type":[{"value":"2949-9283","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rabies virus glycoprotein: Structure, function, and antivirals","name":"articletitle","label":"Article Title"},{"value":"hLife","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlife.2025.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Institute of Microbiology, Chinese Academy of Sciences.","name":"copyright","label":"Copyright"}]}}